How many terms under the parent term'baclofen'in the ICD-10-CM drugs index?
The ICD-10-CM Drugs Index is designed to allow medical coders to look up various medical terms and connect them with the appropriate ICD codes. There are 0 terms under the parent term 'Baclofen' in the ICD-10-CM Drugs Index .
What is the ICD 10 code for UNSP?
2016 2017 2018 2019 Billable/Specific Code. F19.939 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Other psychoactive substance use, unsp with withdrawal, unsp. The 2018/2019 edition of ICD-10-CM F19.939 became effective on October 1, 2018.
What are the signs and symptoms of baclofen withdrawal?
All patients receiving intrathecal baclofen therapy are potentially at risk for withdrawal. Early symptoms of baclofen withdrawal may include return of baseline spasticity, pruritus, hypotension, and paresthesias.
What is ICD-10 code for muscle spasm?
ICD-10 code M62. 83 for Muscle spasm is a medical classification as listed by WHO under the range - Soft tissue disorders .
What is the ICD-10 code for muscle relaxer?
1 - skeletal muscle relaxants.
What is the ICD-10 code for presence of Baclofen pump?
Encounter for adjustment and management of infusion pump Z45. 1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
What is the ICD-10 code for medication?
ICD-10 Codes for Long-term TherapiesCodeLong-term (current) use ofZ79.899other drug therapyH – Not Valid for Claim SubmissionZ79drug therapy21 more rows•Aug 15, 2017
What drug class is baclofen?
Baclofen is in a class of medications called skeletal muscle relaxants.
What is baclofen used for?
Baclofen is used to help relax certain muscles in your body. It relieves the spasms, cramping, and tightness of muscles caused by medical problems, including multiple sclerosis or certain injuries to the spine.
Is a baclofen pump an infusion pump?
Background: Baclofen pumps provide treatment of symptoms of spasticity for disease processes such as cerebral palsy and traumatic brain injury. These devices provide continuous infusion or periodic dosing of intrathecal baclofen (ITB). Traditionally, these pumps have been placed subcutaneously.
What is a baclofen pump?
A baclofen pump is a device that delivers a medication called baclofen to the spinal canal. The baclofen pump is surgically implanted near the abdomen, with a catheter (a thin flexible tube) running to the spinal canal to deliver the medication.
What is the CPT code for baclofen pump?
62360 (Implantation or replacement of device for intrathecal or epidural drug infusion; subcutaneous reservoir).
What is the ICD-10 code for medication review?
Encounter for therapeutic drug level monitoring. Z51. 81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
What is the ICD-10 code for medication refill?
ICD-10 Code for Encounter for issue of repeat prescription- Z76. 0- Codify by AAPC.
What does diagnosis code Z51 81 mean?
Z51. 81 Encounter for therapeutic drug level monitoring - ICD-10-CM Diagnosis Codes.
Indications and Usage
Lioresal ® Intrathecal (baclofen injection) is a muscle relaxant and antispastic that is indicated for use in the management of severe spasticity of cerebral or spinal origin.
Select Warnings and Precautions
It is mandatory that all patients, caregivers, and treating physicians receive adequate information regarding the risks of the mode of treatment.
Adverse Reactions
The most frequent drug adverse events vary by indication but include: hypotonia (34.7%), somnolence (20.9%), headache (10.7%), convulsion (10.0%), dizziness (8.0%), urinary retention (8.0%), nausea (7.3%), and paresthesia (6.7%). Dosing and programming errors may result in clinically significant overdose or withdrawal.
Use in Specific Populations
There are no adequate and well controlled studies in pregnant women. Lioresal ® Intrathecal should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
General Information
CPT codes, descriptions and other data only are copyright 2020 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
CMS National Coverage Policy
Title XVIII Social Security Act, §1833 (e) prohibits Medicare payment for any claim lacking the necessary information to process that claim.
Article Guidance
The information in this article contains billing, coding or other guidelines that complement the Local Coverage Determination (LCD) for Implantable Infusion Pump L33461.
Bill Type Codes
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type.
Revenue Codes
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination.
Contraindications
Drug Information: Refer to appropriate drug labeling for indications, contraindications, warnings, precautions, dosage and administration, screening procedures, and under-/overdose symptoms and methods of management. Patients should be informed of the signs and symptoms of drug under- or overdose, appropriate drug warnings and precautions, and signs and symptoms that re…
An inflammatory mass that can result in serious neurological impairment, including paralysis, may occur at the tip of the implanted catheter. Clinicians should monitor patients carefully for any new neurological signs or symptoms, change in underlying symptoms, or need for rapid dose escalation. Monitor patients appropriately after refill if a pocket fill is suspected. Failure to recog…
Infumorph® is a registered trademark of West-Ward Pharmaceutical. Prialt® is a registered trademark of Jazz Pharmaceuticals plc or its subsidiaries. Lioresal® is a registered trademark of Saol.
LIORESAL INTRATHECAL (baclofen injection) is a muscle relaxant and antispastic. Its chemical name is 4-amino-3-(4-chlorophenyl) butanoic acid, and its structural formula is: LIORESAL INTRATHECAL is a sterile, pyrogen-free, isotonic solution free of antioxidants, preservatives or other potentially neurotoxic additives indicated only for intrathecal ...
Baclofen is a white to off-white, odorless or practically odorless crystalline powder, with a molecular weight of 213.66. It is slightly soluble in water, very slightly soluble in methanol, and insoluble in chloroform.
The precise mechanism of action of baclofen as a muscle relaxant and antispasticity agent is not fully understood. Baclofen inhibits both monosynaptic and polysynaptic reflexes at the spinal level, possibly by decreasing excitatory neurotransmitter release from primary afferent terminals, although actions at supraspinal sites may also occur and contribute to its clinical effect. Baclofe…
In people, as well as in animals, baclofen has been shown to have general CNS depressant properties as indicated by the production of sedation with tolerance, somnolence, ataxia, and respiratory and cardiovascular depression. Pharmacodynamics of LIORESAL INTRATHECAL: LIORESAL INTRATHECAL'S antispastic action is first seen at 6 to 8 hours after initiation of conti…
Adult Patients: The onset of action is generally one-half hour to one hour after an intrathecal bolus. Peak spasmolytic effect is seen at approximately four hours after dosing and effects may last four to eight hours. Onset, peak response, and duration of action may vary with individual patients depending on the dose and severity of symptoms.
Continuous Infusion: The mean CSF clearance for LIORESAL INTRATHECAL (baclofen injection) was approximately 30 mL/hour in a study involving ten patients on continuous intrathecal infusion. Concurrent plasma concentrations of baclofen during intrathecal administration are expected to be low (0- 5 ng/mL).
Six pediatric patients (age 8-18 years) receiving continuous intrathecal baclofen infusion at doses of 77-400 mcg/day had plasma baclofen levels near or below 10 ng/mL.
LIORESAL INTRATHECAL (baclofen injection) is indicated for use in the management of severe spasticity. Patients should first respond to a screening dose of intrathecal baclofen prior to consideration for long term infusion via an implantable pump. For spasticity of spinal cord origin, chronic infusion of LIORESAL INTRATHECAL via an implantable pump should be reserved for pa…
Spasticity of Spinal Cord Origin: Evidence supporting the efficacy of LIORESAL INTRATHECAL was obtained in randomized, controlled investigations that compared the effects of either a single intrathecal dose or a three day intrathecal infusion of LIORESAL INTRATHECAL to placebo in patients with severe spasticity and spasms due to either spinal cord trauma or multiple sclerosi…
Overdose: Signs of overdose may appear suddenly or insidiously. Acute massive overdose may present as coma. Less sudden and/or less severe forms of overdose may present with signs of drowsiness, lightheadedness, dizziness, somnolence, respiratory depression, seizures, rostral progression of hypotonia and loss of consciousness progressing to coma. Should overdose app…
Withdrawal: Abrupt withdrawal of intrathecal baclofen, regardless of the cause, has resulted in sequelae that included high fever, altered mental status, exaggerated rebound spasticity and muscle rigidity that in rare cases progressed to rhabdomyolysis, multiple organ-system failure, and death. In the first 9 years of post-marketing experience, 27 cases of withdrawal temporally r…
Prevention of abrupt discontinuation of intrathecal baclofen requires careful attention to programming and monitoring of the infusion system, refill scheduling and procedures, and pump alarms. Patients and caregivers should be advised of the importance of keeping scheduled refill visits and should be educated on the early symptoms of baclofen withdrawal.
Rapid, accurate diagnosis and treatment in an emergency-room or intensive-care setting are important in order to prevent the potentially life-threatening central nervous system and systemic effects of intrathecal baclofen withdrawal. The suggested treatment for intrathecal baclofen withdrawal is the restoration of intrathecal baclofen at or near the same dosage as before thera…